在资源有限的环境中对心力衰竭的管理:来自印度的专家意见
Peeyush Jain1, Santanu Guha2, Soumitra Kumar3
1Fortis Escorts Heart Institute, New Delhi, India.
Cardiology and therapy
|April 30, 2024
概括
针对心力衰竭的指导指导医学治疗在全球范围内未得到充分利用. 印度的专家共识为优化治疗提供了量身定制的建议,包括早期使用-葡萄糖共运输体2抑制剂,以改善资源有限的环境中的患者结果.
科学领域:
- 心脏病学 心脏病学
- 内部医学 内部医学
- 公共卫生 公共卫生
背景情况:
- 心力衰竭是一个重要的全球健康负担,影响着数百万.
- 对指南导向医学治疗 (GDMT) 的有限准入是一个主要的挑战,由药物可用性,临床惯性和延迟诊断等因素驱动.
- 对GDMT的个性化方法至关重要,特别是在资源有限的环境中.
研究的目的:
- 在资源有限的环境中,制定针对心力衰竭管理中的GDMT量身定制的建议.
- 为了解决印度关键疗法的不足利用情况,如血管激素II受体阻断剂 neprilysin 抑制剂和-葡萄糖共运输体 2 抑制剂.
- 促进专家在患者资料,监测和不利影响方面达成共识,以便有效实施GDMT.
主要方法:
- 专家共识由150名专家 (心脏病学家,病学家,内分泌学家) 组成.
- 审议的重点是患者资料,监测策略和不良副作用的管理.
- 制定了建议,以优化心力衰竭中的GDMT.
主要成果:
- 强调在心力衰竭患者早期启动GDMT,特别强调-葡萄糖共运输体2抑制剂.
- 探索新型治疗药物,如达西瓜特.
- 确定改善心力衰竭结果的关键策略,包括加强患者教育,心脏康复和改善药物获取.
结论:
- 量身定制的GDMT建议对于改善资源有限的环境中的心力衰竭管理至关重要.
- 解决药物获取障碍和实施政策改革对于更广泛地采用有效疗法至关重要.
- 涉及患者教育,康复和政策变化的多方面的方法可以提高心力衰竭的结果.
相关概念视频
01:17Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
01:22Heart Failure Drugs: Diuretics
370
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
370
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
422
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
422
01:22Heart Failure Drugs: β-Blockers
337
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
337
01:26Heart Failure Drugs: Inotropic Agents
574
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
574
01:26Imbalances in Cardiac Output
1.4K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K